PortfoliosLab logo

Arrowhead Pharmaceuticals, Inc.

ARWR
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US04280A1007
CUSIP
04280A100

ARWRPrice Chart


Click Calculate to get results
S&P 500

ARWRPerformance

The chart shows the growth of $10,000 invested in Arrowhead Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $126,611 for a total return of roughly 1,166.11%. All prices are adjusted for splits and dividends.


ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ARWRReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-23.03%
6M-14.56%
YTD-10.90%
1Y40.68%
5Y64.72%
10Y29.44%

ARWRMonthly Returns Heatmap


Click Calculate to get results

ARWRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Arrowhead Pharmaceuticals, Inc. Sharpe ratio is 0.65. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ARWRDividends


ARWR doesn't pay dividends

ARWRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (S&P 500)

ARWRWorst Drawdowns

The table below shows the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Arrowhead Pharmaceuticals, Inc. is 95.33%, recorded on Dec 16, 2016. It took 619 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.33%Mar 11, 2014701Dec 16, 2016619Jun 6, 20191320
-90.86%Jun 7, 2010726Apr 24, 2013202Feb 11, 2014928
-71.84%Dec 2, 201974Mar 18, 2020186Dec 10, 2020260
-32.19%Feb 8, 202135Mar 29, 2021
-27.19%Mar 24, 20103Mar 26, 20102Mar 30, 20105
-25%Jan 26, 201024Mar 1, 201015Mar 22, 201039
-22.66%Aug 30, 201920Sep 27, 201914Oct 17, 201934
-19.35%Apr 30, 20105May 6, 201019Jun 3, 201024
-14.92%Dec 24, 20207Jan 5, 202122Feb 5, 202129
-13.41%Feb 24, 20145Feb 28, 20143Mar 5, 20148

ARWRVolatility Chart

Current Arrowhead Pharmaceuticals, Inc. volatility is 34.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ARWR (Arrowhead Pharmaceuticals, Inc.)
Benchmark (S&P 500)

Portfolios with Arrowhead Pharmaceuticals, Inc.


Loading data...

More Tools for Arrowhead Pharmaceuticals, Inc.